Clinical Significance of the Interleukin 24 mRNA Level in Head and Neck Squamous Cell Carcinoma and Its Subgroups: An In Silico Investigation

Table 1

The relationships between IL24 mRNA levels and clinicopathologic features of the 341 cases of OSCC patients detected by RNA-sequencing.

Parameters	n	Mean	±SD	t	value
Tissues
OSCC	341	4.055	±0.2013	10.973	<0.0001
Non-OSCC	44	3.808	±0.1306
Gender
Male	238	4.047	±0.2134	−1.172	0.242
Female	103	4.073	±0.1694
Age
≥60	190	4.052	±0.2054	−0.268	0.789
＜60	150	4.058	±0.1971
Grade
G1-G2	260	4.068	±0.2006	−1.767	0.078
G3-G4	72	4.021	±0.1946
Pathological stage
I-II	92	4.065	±0.1955	0.598	0.55
III-IV	239	4.051	±0.2048
Pathological T stage
T1-T2	130	4.047	±0.1889	−0.544	0.587
T3-T4	208	4.059	±0.2095
Pathological N stage
N0	173	4.056	±0.1883	0.358	0.721
N1	154	4.048	±0.2175
Pathological M stage
M0	320	4.053	±0.2019	0.881	0.379
M1	2	3.927	±0.3059

Note: OSCC: oral squamous cell carcinoma; G: grade; T: tumor; N: lymph node; M: metastasis.